Neuraltus Pharmaceuticals Lands $14,938,357 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fb1930a7-685c-486d-9fd1-fb4c0fbac841
Date
5/25/2016
Company Name
Neuraltus Pharmaceuticals
Mailing Address
2479 E. Bayshore Road Palo Alto, CA 94303 USA
Company Description
Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders.
Website
http://www.neuraltus.com
Transaction Type
Venture Equity
Transaction Amount
$14,938,357
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed